Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302793 · ClinicalTrials.gov registry record · NA
Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury
A NA study of Pain Management, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT03302793: Completed NA study of Pain Management, sponsored by The University of Texas Health Science Center, Houston.
NCT03302793 is a NA study of Pain Management that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 12 participants, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03302793, a NA study of Pain Management, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at the effect of combined breathing-controlled electrical stimulation (BreEStim) and transcranial direct current stimulation (tDCS) on neuropathic pain after spinal cord injury, amputation, or brain injury. The hypothesis is that a single session of combined BreEStim and tDCS will produce an additive analgesic effect. This record covers the study in a population of spinal cord injury patients. Note that this study will also enroll healthy volunteers, brain injury patients, and amputation patients and that this study as applied to these other populations will be covered in separate ClinicalTrials.gov records.
Primary Outcome
A Visual Analogue Scale (VAS) is a measurement instrument that tries to measure a characteristic or attitude that is believed to range across a continuum of values and cannot easily be directly measured. It is often used in epidemiologic and clinical research to measure the intensity or frequency of various symptoms. To allow a continuous assessment of pain, VAS uses a 10 cm line labelled at '0' with 'no pain' and '10' with 'worst pain'. The line is marked at a point corresponding to the assessm
Conditions Studied
Interventions
- DEVICE tDCS
- DEVICE BreEStim
- DEVICE tDCS sham
Study Locations (1)
Texas
- TIRR - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT03302793 record still lists
NCT03302793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 154-participant average among 31 other Pain Management trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Pain Management appearing as the primary indexed condition, and to 3 interventions - of which tDCS is the first listed.
NCT03302793 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03302793 about?
NCT03302793 is a clinical study titled "Combined Peripheral (BreEStim) and Central Electrical Stimulation (tDCS) for Neuropathic Pain Management - Spinal Cord Injury". This study looks at the effect of combined breathing-controlled electrical stimulation (BreEStim) and transcranial direct current stimulation (tDCS) on neuropathic pain after spinal cord injury, amputation, or brain injury. The hypothesis is that a single session of combined BreEStim and tDCS will p...
What is the current status of trial NCT03302793?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2017-12.
What conditions does trial NCT03302793 study?
This clinical trial studies the following conditions: Pain Management.
What interventions are being tested in trial NCT03302793?
The interventions under investigation include: tDCS (DEVICE), BreEStim (DEVICE), tDCS sham (DEVICE).
Who is sponsoring clinical trial NCT03302793?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03302793 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Management
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03302793's enrollment target sits among peer trials
12 30th of 31 higher than 2 of 31 other Pain Management trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain Management trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
RECRUITING · NA
-
mHealth Intervention for Pain Self Management
RECRUITING · NA
-
Sensory Spinal Cord Stimulation
RECRUITING · NA
-
Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention
RECRUITING · NA
-
Post-Operative Analgesic Selection in Patients Planned for Third Molar Extraction After Undergoing Shared Decision Making Using 2- Versus 3-Option Decision-Aids
RECRUITING · NA
-
PEACE: Comparing Chronic Pain Treatment Options
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia